Treating Tobacco Use Within Lung Cancer Screening Programs Is Optimal

Affiliations

Judith J Prochaska. JAMA Intern Med. 2025.

. 2025 Mar 1;185(3):291-292.

doi: 10.1001/jamainternmed.2024.7297.

¹ Stanford Prevention Research Center, Department of Medicine, School of Medicine, Stanford University, Palo Alto, California.

No abstract available

Comment in

Smoking Cessation Interventions in the Lung Cancer Screening Setting: A Randomized Clinical Trial.
Cinciripini PM, Minnix JA, Kypriotakis G, Erasmus J, Beneventi D, Karam-Hage M, Carpenter K, Volk RJ, Carter B, Godoy MCB, Strange C, Shih YT, Cui Y, Green CE, Robinson JD. Cinciripini PM, et al. JAMA Intern Med. 2025 Mar 1;185(3):284-291. doi: 10.1001/jamainternmed.2024.7288. JAMA Intern Med. 2025. PMID: 39804633 Clinical Trial.